- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Procter & Gamble Health Share Price
Procter & Gamble Health Ltd.
₹5,459
101.00(1.89%)
Invest in PGHL with up to 3.33x margin.
Trade with MTF21st May 2026 | 3:28 PM
NSE : PGHL
Open Free Demat Account
Procter & Gamble Health Performance
Price Movement
₹5459.00
₹5318.50
₹5475.00
↘ Today's Low↗ Today's High
1 Year Performance
₹5459.00
₹4707.00
₹6739.00
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹5,475.00
Low₹5,318.50
Open at₹5,365.00
Prev Close₹5,358.00
Volumes25.05 K
Avg Price₹5,411.48
Lower Circuit₹4,286.50
Upper Circuit₹6,429.50
Historical Performance
3M High₹5,420.00
3M Low₹4,707.00
1 Yr High₹6,739.00
1 Yr Low₹4,707.00
3 Yr High₹6,739.00
3 Yr Low₹4,636.55
5 Yr High₹6,739.00
5 Yr Low₹3,870.10
Procter & Gamble Health Fundamentals
Market Cap
Above industry Median
8,894 Cr.
PE Ratio (TTM)
Above industry Median
30.30
Dividend Yield
Market Runner Up
3.80
Net Profit TTM
24.1% incr over last year
293.49
Net Profit Growth
24.1% incr over last year
293.49
PEG Ratio
Above industry Median
1.30
ROE
16.9% incr over last year
43.65
Operating Revenue TTM
1,348.51
Operating Revenue Growth
16.3% incr over last year
Book Value
High in industry
12.80
MFI
MFI is mid-range
57.03
RSI
RSI is mid-range
60.33
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
12.80
Procter & Gamble Health Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 373.86 | 324.92 | 338.74 | 310.99 | 309.77 |
| Operating Expense | 263.40 | 204.65 | 248.40 | 230.07 | 186.34 |
| Operating Profit | 110.46 | 120.27 | 90.34 | 80.92 | 123.43 |
| Depreciation | 5.90 | 6.08 | 5.44 | 5.37 | 5.55 |
| Interest | 0.10 | 0.12 | 0.12 | 0.13 | 0.15 |
| Tax | 31.23 | 30.48 | 22.63 | 17.35 | 30.79 |
| Net Profit | 77.59 | 88.54 | 66.18 | 61.18 | 90.90 |
Procter & Gamble Health Technicals
Procter & Gamble Health Ltd. EMA & SMA
₹5459.00
118.50 (2.22%)
↗ Bullish Moving Average
13
↘ Bearish Moving Average
3
Day EMA5 ₹5283.6
Day EMA10 ₹5256.5
Day EMA12 ₹5245.4
Day EMA20 ₹5199.8
Day EMA26 ₹5171.8
Day EMA50 ₹5137.8
Day EMA100 ₹5239
Day EMA200 ₹5400.2
Procter & Gamble Health Support and Resistance
Resistance
First Resistance₹5397.00
Second Resistance₹5453.50
Third Resistance₹5542.00
Support
First Support₹5252.00
Second Support₹5163.50
Third Support₹5107.00
Technical Indicators
Day RSI60.33
Day MFI57.03
Day ADX30.02
Day Commodity Channel Index98.00
William-22.52
Day MACD73.57
Day MACD Signal Line72.02
Day ATR124.87
Day ROC125-8.78
Day ROC216.32
Procter & Gamble Health Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 | 51.8 |
| FII | 7 | 6.9 | 7 | 7.2 | 7 | 6.2 |
| DII | 14.7 | 14.2 | 14.1 | 13.9 | 13.8 | 13.7 |
| Public | 26.5 | 27.1 | 27 | 27 | 27.4 | 28.3 |
Procter & Gamble Health Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 27.14 K | 30.39 K | 89.31% |
| Week | 10.32 K | 15.16 K | 68.07% |
| 1 Month | 9.93 K | 16.1 K | 61.66% |
| 6 Month | 9.1 K | 14.32 K | 63.56% |
Procter & Gamble Health SWOT Analysis
Strengths15
Weakness5
Opportunity1
Threats1
MACD Crossover Above Signal Line
Companies with no Debt
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Zero Promoter Pledge
RSI indicating price strength
MACD crossed above signal line previous end of day
Top Gainers
Procter & Gamble Health Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 12 Feb, 2026 | 50 | SPECIAL | 12 Feb, 2026 | Equity Share |
| 12 Feb, 2026 | 110 | INTERIM | 12 Feb, 2026 | Equity Share |
| 22 Aug, 2025 | 45 | FINAL | 22 Aug, 2025 | Equity Share |
| 21 Feb, 2025 | 80 | INTERIM | 21 Feb, 2025 | Equity Share |
| 28 Nov, 2024 | 60 | FINAL | Equity Share | |
| 14 Feb, 2024 | 150 | SPECIAL | 14 Feb, 2024 | Equity Share |
| 14 Feb, 2024 | 50 | INTERIM | 14 Feb, 2024 | Equity Share |
| 23 Nov, 2023 | 50 | FINAL | Equity Share | |
| 13 Feb, 2023 | 45 | INTERIM | 13 Feb, 2023 | Equity Share |
| 15 Nov, 2022 | 11.5 | FINAL | Equity Share |
Procter & Gamble Health Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,720 | ₹665 | ₹967.50 | ₹523.45 | ₹870.50 | ₹1,121 |
| % Change | -0.68% | 2.29% | -1.88% | 1.65% | -1.10% | 0.45% |
| Revenue TTM (₹ Cr) | ₹1,403.18 | - | ₹1,598.19 | ₹4,359.02 | ₹1,630.02 | ₹1,158.69 |
| Net Profit TTM (₹ Cr) | ₹185.12 | - | ₹206.20 | ₹255.19 | ₹140.92 | ₹312.50 |
| PE TTM | 57.20 | - | 78.90 | 31.80 | 35.70 | 37.40 |
| 1 Year Return | 63.07 | 9.63 | 103.31 | -6.77 | -4.7 | -26.82 |
| ROCE | 31.54 | 34.78 | 34.76 | 11.40 | 15.27 | 26.82 |
Similar Stocks
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 705.00
+0.61%
SUPRIYA
Supriya Lifescience Ltd.
₹ 740.00
+2.03%
SYNGENE
Syngene International Ltd.
₹ 468.20
+0.46%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 745.00
-0.98%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 180.00
-2.00%
STAR
Strides Pharma Science Ltd.
₹ 1163.50
+1.91%
FDC
FDC Ltd.
₹ 363.00
-0.17%
SHILPAMED
Shilpa Medicare Ltd.
₹ 476.00
-0.06%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 1011.00
-0.32%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 2011.00
-0.28%
MARKSANS
Marksans Pharma Ltd.
₹ 217.00
-0.19%
SANOFI
Sanofi India Ltd.
₹ 3190.00
+0.00%
JSLL
Jeena Sikho Lifecare Ltd.
₹ 658.80
+1.26%
FAQ's on PGHL
What is the current share price of Procter & Gamble Health Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Procter & Gamble Health Ltd. is ₹ 5459 on the NSE and ₹ 5458.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Procter & Gamble Health Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Procter & Gamble Health Ltd. is approximately ₹ 8894 Cr.
What are the PE and PB ratios for Procter & Gamble Health Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Procter & Gamble Health Ltd. is 30.3, and the Price-to-Book (PB) ratio is 12.8.
What is the 52-Week High and Low for Procter & Gamble Health Ltd.?
Over the past 52 weeks, the highest price reached by Procter & Gamble Health Ltd. shares was ₹ 6739, and the lowest price was ₹ 4707.
What is the current dividend yield for Procter & Gamble Health Ltd.?
As of 6 June 2025, the dividend yield for Procter & Gamble Health Ltd. is 3.8%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Procter & Gamble Health Ltd.?
Significant shareholdings in Procter & Gamble Health Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Public
- Mutual Funds
- FII
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Procter & Gamble Health Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Procter & Gamble Health Ltd. is often compared with other major players such as
Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.
What is the latest dividend information for Procter & Gamble Health Ltd.?
Procter & Gamble Health Ltd. last declared a SPECIAL dividend of ₹ 50 per share for the financial period ending 2026. The record date was set as 2026-02-12, and the payment was/is scheduled around 2026-02-12. For the most current dividend announcements, refer to official company filings.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy